When is the AbbVie (ABBV) dividend payment date for the $1.73 per share dividend?

The $1.73 per share AbbVie dividend is payable on August 14, 2026. According to AbbVie, shareholders who are on record by the July 15, 2026 record date will receive this quarterly cash dividend payment on the scheduled date.

AbbVie Declares Quarterly Dividend

Q: What quarterly dividend did AbbVie (ABBV) declare on June 18, 2026?

AbbVie declared a quarterly cash dividend of $1.73 per share. According to AbbVie, this dividend continues its long-term focus on returning cash to shareholders while maintaining a record of significant dividend growth since the company’s inception in 2013.

Q: What is the record date for AbbVie’s August 14, 2026 dividend payment (ABBV)?

The record date for AbbVie’s $1.73 per share dividend is July 15, 2026. According to AbbVie, investors must be stockholders of record at the close of business on that date to qualify for the August 14, 2026 dividend payment.

Q: How much has AbbVie (ABBV) increased its dividend since 2013?

AbbVie reports it has increased its dividend by more than 330% since 2013. According to AbbVie, this growth in the dividend reflects its commitment to shareholder returns and supports its inclusion in the S&P Dividend Aristocrats Index of consistent dividend growers.

Q: Is AbbVie (ABBV) part of the S&P Dividend Aristocrats Index?

Yes, AbbVie is a member of the S&P Dividend Aristocrats Index. According to AbbVie, this index tracks companies that have raised their dividend every year for at least 25 consecutive years, highlighting AbbVie’s consistent dividend growth profile for income-focused investors.

AbbVie (NYSE: ABBV) announced its board declared a quarterly cash dividend of $1.73 per share.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

AbbVie (NYSE: ABBV) announced its board declared a quarterly cash dividend of $1.73 per share. The dividend is payable August 14, 2026, to shareholders of record on July 15, 2026. Since 2013, AbbVie has raised its dividend by over 330% and is part of the S&P Dividend Aristocrats Index.

Positive

Quarterly cash dividend of $1.73 per share declared
Dividend payable on August 14, 2026
Shareholders of record on July 15, 2026 qualify
Dividend has increased by over 330% since 2013 inception
Membership in S&P Dividend Aristocrats Index highlights long-term dividend growth record

Negative

None.

Argus Jun 22 session

+6.25% close to close Open Argus

Details

News Market Reaction – ABBV

On Jun 22, the first trading day after this news, ABBV closed 6.25% above the previous close.

Data tracked by StockTitan Argus for the Jun 22 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

06/18/2026 - 04:05 PM EDT

NORTH CHICAGO, Ill., June 18, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.

The cash dividend is payable August 14, 2026, to stockholders of record at the close of business on July 15, 2026.

Since the company's inception in 2013, AbbVie has increased its dividend by more than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Media:

Marianne Ostrogorski

(224) 240-6336

Investors:

Liz Shea

(847) 935-2211

marianne.ostrogorski@abbvie.com

liz.shea@abbvie.com

View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302804858.html

SOURCE AbbVie

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What quarterly dividend did AbbVie (ABBV) declare on June 18, 2026?

AbbVie declared a quarterly cash dividend of $1.73 per share. According to AbbVie, this dividend continues its long-term focus on returning cash to shareholders while maintaining a record of significant dividend growth since the company’s inception in 2013.

What is the record date for AbbVie’s August 14, 2026 dividend payment (ABBV)?

The record date for AbbVie’s $1.73 per share dividend is July 15, 2026. According to AbbVie, investors must be stockholders of record at the close of business on that date to qualify for the August 14, 2026 dividend payment.

How much has AbbVie (ABBV) increased its dividend since 2013?

AbbVie reports it has increased its dividend by more than 330% since 2013. According to AbbVie, this growth in the dividend reflects its commitment to shareholder returns and supports its inclusion in the S&P Dividend Aristocrats Index of consistent dividend growers.

Is AbbVie (ABBV) part of the S&P Dividend Aristocrats Index?

Yes, AbbVie is a member of the S&P Dividend Aristocrats Index. According to AbbVie, this index tracks companies that have raised their dividend every year for at least 25 consecutive years, highlighting AbbVie’s consistent dividend growth profile for income-focused investors.

AbbVie Declares Quarterly Dividend